| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.90 | $54.06 (0%) | 🛒 Add to cart |
| 90 | $0.75 | $81.09 $67.07 (17%) | 🛒 Add to cart |
| 120 | $0.67 | $108.12 $80.09 (26%) | 🛒 Add to cart |
| 180 | $0.59 | $162.18 $106.12 (35%) | 🛒 Add to cart |
| 270 | $0.54 | $243.27 $145.16 (40%) | 🛒 Add to cart |
| 360 | $0.51
Best per pill | $324.36 $184.20 (43%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.85 | $51.06 (0%) | 🛒 Add to cart |
| 90 | $0.73 | $76.58 $66.07 (14%) | 🛒 Add to cart |
| 120 | $0.68 | $102.11 $81.09 (21%) | 🛒 Add to cart |
| 180 | $0.61 | $153.17 $110.12 (28%) | 🛒 Add to cart |
| 270 | $0.57 | $229.75 $154.17 (33%) | 🛒 Add to cart |
| 360 | $0.55
Best per pill | $306.34 $199.22 (35%) | 🛒 Add to cart |
Synonyms
| |||
Similar products
More info:
nolvadex
Nolvadex, known generically as tamoxifen citrate, is a selective estrogen receptor modulator (SERM) with a well-established role in oncology and endocrine therapy. Originally developed in the 1960s, it has become a cornerstone in the management of hormone receptor-positive breast cancer. Unlike aromatase inhibitors, which work by reducing estrogen production, Nolvadex functions by competitively binding to estrogen receptors in certain tissues, acting as an antagonist in breast tissue while having partial agonist effects in others like bone and endometrium.
tamoxifen
Tamoxifen citrate represents one of the most significant advances in oncology pharmacology over the past half-century. As a selective estrogen receptor modulator (SERM), this medication occupies a unique therapeutic niche, functioning as both an antagonist and partial agonist depending on the target tissue. Originally developed in the 1960s by Imperial Chemical Industries, tamoxifen’s journey from laboratory curiosity to cornerstone breast cancer therapy illustrates the unpredictable nature of drug development. What began as a failed contraceptive has become the most prescribed hormonal therapy for breast cancer worldwide, with over a dozen generic formulations now available.
a ret gel
Product Description: A Ret Gel represents a significant advancement in topical retinoid therapy, combining stabilized tretinoin with enhanced penetration technology. This medical-grade formulation addresses the fundamental challenge of retinoid instability while maximizing bioavailability. The gel matrix creates a controlled-release environment that maintains tretinoin’s molecular integrity while minimizing the irritation commonly associated with traditional retinoid formulations. What sets this apart isn’t just the active ingredient—it’s the delivery system that makes the difference in clinical outcomes.
abana
Product Description: Abana represents one of those interesting formulations that bridges traditional Ayurvedic wisdom with modern cardiovascular science. I first encountered it during my cardiology fellowship when our department was exploring integrative approaches to lipid management. The formula combines herbs like Terminalia arjuna, Withania somnifera, and Ocimum sanctum with minerals in a specific preparation that’s been used for decades, though Western literature has been slow to catch up. ## 1. Introduction: What is Abana?
abhigra
Product Description Abhigra represents a novel class of phytopharmaceutical-grade dietary supplements derived from a standardized extract of Boswellia serrata, specifically optimized for enhanced bioavailability. Unlike conventional boswellia supplements, Abhigra utilizes a proprietary lipid-based delivery system that significantly increases the absorption of the active boswellic acids, particularly AKBA (3-O-acetyl-11-keto-β-boswellic acid). The formulation was developed through a collaboration between rheumatologists and pharmacognosy experts who recognized the limitations of existing anti-inflammatory supplements. We kept hitting the same wall with patients - they’d take standard boswellia products but achieve negligible serum levels.
abilify
Aripiprazole, marketed under the brand name Abilify, represents a significant advancement in the atypical antipsychotic class with its unique pharmacodynamic profile. This second-generation antipsychotic functions as a partial dopamine D2 and serotonin 5-HT1A receptor agonist while simultaneously acting as a 5-HT2A receptor antagonist. The clinical implications of this mechanism are profound, offering stabilization of dopamine neurotransmission rather than complete blockade, which translates to improved tolerability regarding extrapyramidal symptoms and prolactin elevation compared to conventional antipsychotics.
Acamprol: Neurotransmitter Modulation for Cognitive and Neurological Support - Evidence-Based Review
Product Description Acamprol is an orally administered dietary supplement specifically formulated to support neurological health and cognitive function. It falls into the category of medical foods or nutraceuticals designed to provide targeted nutritional support for conditions involving neurotransmitter imbalance and neuronal excitability. The product is typically available in delayed-release tablet form, intended to ensure optimal absorption in the gastrointestinal tract. Its development was driven by the growing need for non-pharmaceutical interventions in managing functional neurological symptoms, particularly in cases where conventional medications are contraindicated or poorly tolerated.
Accufine: Continuous Glucose Monitoring Without Calibration - Evidence-Based Review
Product Description Accufine represents a significant advancement in non-invasive blood glucose monitoring technology. This Class II medical device utilizes a proprietary multi-sensor array with advanced photoplethysmography and impedance spectroscopy to provide continuous glucose readings without fingerstick calibration. The system consists of a discreet wearable sensor that transmits data to a dedicated mobile application, allowing patients and clinicians to track glycemic patterns in real-time. What sets Accufine apart isn’t just the technology itself, but how we arrived at this particular configuration - a journey marked by both breakthroughs and considerable setbacks that nearly derailed the project entirely.
accupril
Accupril is a well-established angiotensin-converting enzyme (ACE) inhibitor, specifically quinapril hydrochloride, used primarily in the management of hypertension and as adjunctive therapy in heart failure. It works by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby promoting vasodilation and reducing aldosterone secretion, which decreases sodium and water retention. This monograph provides a comprehensive, evidence-based review of Accupril, detailing its clinical applications, pharmacokinetics, safety profile, and practical considerations for use, aimed at healthcare professionals and informed patients seeking in-depth understanding.